104 related articles for article (PubMed ID: 10618628)
1. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
Carneiro F; Sobrinho-Simoes M
Cancer; 2000 Jan; 88(1):238-40. PubMed ID: 10618628
[No Abstract] [Full Text] [Related]
2. The prognostic significance of amplification and overexpression of c-met and c-erb B-2 in human gastric carcinomas.
Nakajima M; Sawada H; Yamada Y; Watanabe A; Tatsumi M; Yamashita J; Matsuda M; Sakaguchi T; Hirao T; Nakano H
Cancer; 1999 May; 85(9):1894-902. PubMed ID: 10223227
[TBL] [Abstract][Full Text] [Related]
3. MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.
Lee HE; Kim MA; Lee HS; Jung EJ; Yang HK; Lee BL; Bang YJ; Kim WH
Br J Cancer; 2012 Jul; 107(2):325-33. PubMed ID: 22644302
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of the c-met protooncogene in human gastric carcinoma--correlation to clinical features.
Huang TJ; Wang JY; Lin SR; Lian ST; Hsieh JS
Acta Oncol; 2001; 40(5):638-43. PubMed ID: 11669338
[TBL] [Abstract][Full Text] [Related]
5. c-erb B-2 expression is associated with tumor location and venous invasion and influences survival of patients with gastric carcinoma.
Pinto-de-Sousa J; David L; Almeida R; Leitão D; Preto JR; Seixas M; Pimenta A
Int J Surg Pathol; 2002 Oct; 10(4):247-56. PubMed ID: 12490974
[TBL] [Abstract][Full Text] [Related]
6. Association of HER2 gene amplification and tumor progression in early gastric cancer.
Kanayama K; Imai H; Usugi E; Shiraishi T; Hirokawa YS; Watanabe M
Virchows Arch; 2018 Nov; 473(5):559-565. PubMed ID: 30120594
[TBL] [Abstract][Full Text] [Related]
7. MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.
Zhang J; Guo L; Liu X; Li W; Ying J
Oncotarget; 2017 Feb; 8(6):10264-10273. PubMed ID: 28052014
[TBL] [Abstract][Full Text] [Related]
8. The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.
Janbabai G; Oladi Z; Farazmandfar T; Taghvaei T; Naghshvar F
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1945-52. PubMed ID: 25820598
[TBL] [Abstract][Full Text] [Related]
9. HER-2/neu amplification is an independent prognostic factor in gastric cancer.
Park DI; Yun JW; Park JH; Oh SJ; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Yoo CH; Son BH; Cho EY; Chae SW; Kim EJ; Sohn JH; Ryu SH; Sepulveda AR
Dig Dis Sci; 2006 Aug; 51(8):1371-9. PubMed ID: 16868827
[TBL] [Abstract][Full Text] [Related]
10. Amplification and overexpression of c-met gene in Epstein-Barr virus-associated gastric carcinomas.
Kijima Y; Hokita S; Yoshinaka H; Itoh T; Koriyama C; Eizuru Y; Akiba S; Aikou T
Oncology; 2002; 62(1):60-5. PubMed ID: 11810045
[TBL] [Abstract][Full Text] [Related]
11. [Increased expression of the c-Met receptor mRNA in gastric cancer].
Amemiya H; Peña A; Chiurillo M; Moscoso J; Useche A; Baffi R
Invest Clin; 2013 Sep; 54(3):284-98. PubMed ID: 24354242
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients.
Fuse N; Kuboki Y; Kuwata T; Nishina T; Kadowaki S; Shinozaki E; Machida N; Yuki S; Ooki A; Kajiura S; Kimura T; Yamanaka T; Shitara K; Nagatsuma AK; Yoshino T; Ochiai A; Ohtsu A
Gastric Cancer; 2016 Jan; 19(1):183-91. PubMed ID: 25682441
[TBL] [Abstract][Full Text] [Related]
13. Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1.
Yang Y; Wang C; Dai C; Liu X; Li W; Huang M; Zhao X; Ji D; Li J; Guo W
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):547-557. PubMed ID: 33693450
[TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of altered human epidermal growth factor receptors (HERs) in gastric carcinomas: HER2 and HER3 are predictors of poor outcome.
Begnami MD; Fukuda E; Fregnani JH; Nonogaki S; Montagnini AL; da Costa WL; Soares FA
J Clin Oncol; 2011 Aug; 29(22):3030-6. PubMed ID: 21709195
[TBL] [Abstract][Full Text] [Related]
15. Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm.
Park CK; Park JS; Kim HS; Rha SY; Hyung WJ; Cheong JH; Noh SH; Lee SK; Lee YC; Huh YM; Kim H
Oncotarget; 2016 Nov; 7(44):72099-72112. PubMed ID: 27765925
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the c-met, c-erbB-2 and epidermal growth factor receptor gene in human gastric cancers: correlation to clinical features.
Tsugawa K; Yonemura Y; Hirono Y; Fushida S; Kaji M; Miwa K; Miyazaki I; Yamamoto H
Oncology; 1998; 55(5):475-81. PubMed ID: 9732228
[TBL] [Abstract][Full Text] [Related]
17. [Study of gastric carcinoma and PCNA and c-met gene abnormality].
Ji J; Zhao P; Huang B
Wei Sheng Yan Jiu; 2008 Jul; 37(4):479-82. PubMed ID: 18839537
[TBL] [Abstract][Full Text] [Related]
18. MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
Kim HS; Chon HJ; Kim H; Shin SJ; Wacheck V; Gruver AM; Kim JS; Rha SY; Chung HC
J Surg Oncol; 2018 Jun; 117(8):1679-1686. PubMed ID: 29790169
[TBL] [Abstract][Full Text] [Related]
19. Increased gene copy number of HER2 and concordant protein overexpression found in a subset of eyelid sebaceous gland carcinoma indicate HER2 as a potential therapeutic target.
Lee MJ; Kim N; Choung HK; Choe JY; Khwarg SI; Kim JE
J Cancer Res Clin Oncol; 2016 Jan; 142(1):125-33. PubMed ID: 26141290
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneous target protein expression in synchronous multiple gastric carcinomas.
Kang G; Park HY; Ahn S; Kim KM; Park CK; Choi MG; Sohn TS; Bae JM; Kim S
Anal Quant Cytopathol Histpathol; 2013 Feb; 35(1):27-35. PubMed ID: 23469621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]